The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury
Open accessAbstract
Ceruloplasmin is a ferroxidase that oxidizes toxic ferrous iron to its nontoxic ferric form. We have previously reported that a glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed in the mammalian CNS. To better understand the role of ceruloplasmin in iron homeostasis in the CNS, we generated a ceruloplasmin gene-deficient (Cp(-/-)) mouse. Adult Cp(-/-) mice showed increased iron deposition in several regions of the CNS such as the cerebellum and brainstem. Increased lipid peroxidation was also seen in some CNS regions. Cerebellar cells from neonatal Cp(-/-) mice were also more susceptible to oxidative stress in vitro. Cp(-/-) mice showed deficits in motor coordination that were associated with a loss of brainstem dopaminergic neurons. These results indicate that ceruloplasmin plays an important role in maintaining iron homeostasis in the CNS and in protecting the CNS from iron-mediated free radical injury. Therefore, the antioxidant effects of ceruloplasmin could have important implications for various neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease in which iron deposition is known to occur.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceruloplasmin dysfunction might be associated with Parkinson’s disease.135,136”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [135]
In the citing paper
“Ferritin H is induced by NF-κB in response to TNF-α treatment, resulting in suppression of ROS and inhibition of apoptosis (243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
In the citing paper
“NF-κB is activated by TNF-α and has been shown to induce mouse and human ferritin H (171, 243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
In the citing paper
“Ferritin H was found as a TNF-α– or IL-1–inducible gene (171, 243, 294).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
In the citing paper
“Apoptosis induced by TNF-α was inhibited by NF-κB”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
In the citing paper
“Many studies set a precedent of ferritin in cytoprotection against free-iron–catalyzed production of ROS (227, 243, 301).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
In the citing paper
“Ferritin was identified as the downstream mediator of the antioxidant and protective activities of NF-κB in response to TNF-α signaling in inflammation and apoptosis (243, 294).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [243]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansen, M., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,488
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Toxicity of iron and hydrogen peroxide: the Fenton reaction
Winterbourn, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03532-x · Cited by 1,415
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084
A radical hypothesis for neurodegeneration
Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
Gerlach, M., Ben‐Shachar, D., Riederer, P. F., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 704
Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W. P. J. M., & Caroni, P. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02534.2000 · Cited by 683
The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.
Osaki, S., Johnson, D. A., & Frieden, E. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96527-0 · Cited by 679
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Current research on acute phase proteins in veterinary diagnosis: an overview
Murata, H., Shimada, N., & Yoshioka, M. (2003) · The Veterinary Journal · doi:10.1016/s1090-0233(03)00119-9 · Cited by 1,108
Duce, J. A., Tsatsanis, A., Cater, M. A., James, S., Robb, E. L., Wikhe, K., Leong, S. L., Perez, K. A., Johanssen, T., Greenough, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.014 · Cited by 695
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 594
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
Intracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
Iron metabolism in the CNS: implications for neurodegenerative diseases
Rouault, T. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3453 · Cited by 496
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
A delicate balance: Iron metabolism and diseases of the brain
Hare, D. J., Ayton, S., Bush, A. I., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 459
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 447
The Antioxidants and Pro-Antioxidants Network: An Overview
Vertuani, S., Angusti, A., & Manfredini, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384655 · Cited by 449
Role of oxidative stress in epileptic seizures
Shin, E., Jeong, J. H., Chung, Y. H., Kim, W.-K., Ko, K.-H., Bach, J., Hong, J., Yoneda, Y., & Kim, H. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.025 · Cited by 424
Chen, Z., & Trapp, B. D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13062 · Cited by 431
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
“Mice lacking ceruloplasmin, demonstrate at most mild retinal changes, likely because a second ferroxidase, hephaestin, can compensate for the loss (Harris et al., 1999; Patel et al., 2002; Vulpe et al., 1999).”
BackgroundJeong, S. Y., & David, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301988200 · Cited by 377
Self-citationIron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369
Metabolic crossroads of iron and copper
Collins, J. F., Prohaska, J. R., & Knutson, M. D. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00271.x · Cited by 367
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 291
Eid, R., Arab, N. T. T., & Greenwood, M. T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 297
Hahn, P., Qian, Y., Dentchev, T., Chen, L., Beard, J., Harris, Z. L., & Dunaief, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405146101 · Cited by 264
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264
Iron homeostasis and toxicity in retinal degeneration
He, X., Hahn, P., Iacovelli, J., Wong, R., King, C., Bhisitkul, R., Massaro-Giordano, M., & Dunaief, J. L. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.07.004 · Cited by 260
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Chen, L., Shen, Q., Liu, Y., Zhang, Y., Sun, L., Ma, X., Song, N., & Xie, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02071-0 · Cited by 279
Garza-Lombó, C., Posadas, Y., Quintanar, L., Gonsebatt, M. E., & Franco, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7272 · Cited by 263
The long history of iron in the Universe and in health and disease
Sheftel, A. D., Mason, A. B., & Ponka, P. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.002 · Cited by 244
The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review
Moos, T., & Morgan, E. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.002 · Cited by 234
Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
Bisaglia, M., & Bubacco, L. (2020) · Biomolecules · doi:10.3390/biom10020195 · Cited by 226
Galy, B., Ferring–Appel, D., Miñana, B., Bell, O., Janser, H., Muckenthaler, M. U., Schümann, K., & Hentze, M. W. (2005) · Blood · doi:10.1182/blood-2005-04-1365 · Cited by 224
Carrı̀, M. T., Ferri, A., Cozzolino, M., Calabrese, L., & Rotilio, G. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00179-5 · Cited by 209
Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208
Multi-Copper Oxidases and Human Iron Metabolism
Vashchenko, G., & MacGillivray, R. T. A. (2013) · Nutrients · doi:10.3390/nu5072289 · Cited by 223
Sharma, V., Mishra, M., Ghosh, S., Tewari, R., Basu, A., Seth, P., & Sen, E. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.01.016 · Cited by 202
Kitzberger, R., Madl, C., & Ferenci, P. (2005) · Metabolic Brain Disease · doi:10.1007/s11011-005-7910-8 · Cited by 202
Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis
Luoqian, J., Yang, W., Ding, X., Tuo, Q., Xiang, Z., Zheng, Z., Guo, Y., Li, L., Guan, P., Ayton, S., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00883-0 · Cited by 189
Brain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 188
Barnes, N. L., Tsivkovskii, R., Tsivkovskaia, N. O., & Lutsenko, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413840200 · Cited by 176
Boll, M.-C., Alcaraz-Zubeldia, M., Montes, S., & Rios, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9610-3 · Cited by 173
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Levi, S., & Finazzi, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00099 · Cited by 164
Ceruloplasmin and what it might do
Healy, J., & Tipton, K. F. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0687-7 · Cited by 166
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 163
Iron, ferroptosis, and ischemic stroke
Guo, J., Tuo, Q., & Lei, P. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15807 · Cited by 163
Aceruloplasminemia: An Inherited Neurodegenerative Disease with Impairment of Iron Homeostasis
XU, X., PIN, S., GATHINJI, M., FUCHS, R., & HARRIS, Z. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.024 · Cited by 160
Unexpected role of ceruloplasmin in intestinal iron absorption
Cherukuri, S., Potla, R., Sarkar, J., Nurko, S., Harris, Z. L., & Fox, P. L. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.003 · Cited by 163
Dunaief, J. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0568 · Cited by 154
Wong, B. X. W., Tsatsanis, A., Lim, L. Q., Adlard, P. A., Bush, A. I., & Duce, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114174 · Cited by 155
Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases
Jha, M. K., Kim, J.-H., Song, G. J., Lee, W., Lee, I. K., Lee, H., An, S. S. A., Kim, S., & Suk, K. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.003 · Cited by 156
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Percário, S., Barbosa, A. D. S., Varela, E. L. P., Gomes, A. R. Q., Ferreira, M. E. S., Moreira, T. D. N. A., & Dolabela, M. F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2360872 · Cited by 158
Role of the syncytium in placenta-mediated complications of preeclampsia
Guller, S. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.05.016 · Cited by 151
Iron Homeostasis Disorder and Alzheimer’s Disease
Peng, Y., Chang, X., & Lang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212442 · Cited by 146
Jeong, S. Y., & David, S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2922-06.2006 · Cited by 149
Self-citationPyatha, S., Kim, H., Lee, D., & Kim, K. (2022) · Antioxidants · doi:10.3390/antiox11122467 · Cited by 140
Pathophysiology and Clinical Features of Wilson Disease
Ferenci, P. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043973.10494.85 · Cited by 137
Lipid Peroxidation in Muscle Foods: Impact on Quality, Safety and Human Health
Dragoev, S. G. (2024) · Foods · doi:10.3390/foods13050797 · Cited by 148
Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: implication for function
Stoj, C. S., & Kosman, D. J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01218-3 · Cited by 132
David, S., Jhelum, P., Ryan, F., Jeong, S. Y., & Kroner, A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0218 · Cited by 134
Self-citationJin, L., Wang, J., Zhao, L., Jin, H., Fei, G., Zhang, Y., Zeng, M., & Zhong, C. (2010) · Brain · doi:10.1093/brain/awq319 · Cited by 129
Impact of Copper Limitation on Expression and Function of Multicopper Oxidases (Ferroxidases)
Prohaska, J. R. (2011) · Advances in Nutrition · doi:10.3945/an.110.000208 · Cited by 130
Iron homeostasis in astrocytes and microglia is differentially regulated by TNF‐α and TGF‐β1
Rathore, K. I., Redensek, A., & David, S. (2012) · Glia · doi:10.1002/glia.22303 · Cited by 130
Self-citationDunning, M., Lakatos, A., Loizou, L., Kettunen, M. I., ffrench‐Constant, C., Brindle, K. M., & Franklin, R. J. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3126-04.2004 · Cited by 126
Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3768-11.2011 · Cited by 125
Chang, E. F., Wong, R. J., Vreman, H. J., Igarashi, T., Galo, E., Sharp, F. R., Stevenson, D. K., & Noble‐Haeusslein, L. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03689.2003 · Cited by 122
Miyajima, H. (2014) · Neuropathology · doi:10.1111/neup.12149 · Cited by 120
Redox Cycling in Iron Uptake, Efflux, and Trafficking
Kosman, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113217 · Cited by 127
Iron, neuroinflammation, and Alzheimer's disease
Ong, W.-Y., & Farooqui, A. A. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8211 · Cited by 119
Retinal iron homeostasis in health and disease
Song, D., & Dunaief, J. L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00024 · Cited by 122
Copper handling by astrocytes: Insights into neurodegenerative diseases
Tiffany-Castiglioni, E., Hong, S. J., & Qian, Y. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.09.004 · Cited by 116
Najafi, P., ZULKIFLI, I., Jajuli, N. A., Farjam, A. S., Ramiah, S. K., Amir, A. A., O'Reily, E., & Eckersall, P. D. (2015) · International Journal of Biometeorology · doi:10.1007/s00484-015-0964-3 · Cited by 116
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0242-8 · Cited by 119
Moos, T., & Morgan, E. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02142.x · Cited by 113
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144276.29988.c3 · Cited by 111
Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer’s and Parkinson’s diseases
Stelmashook, E. V., Исаев, Н. К., Генрихс, Е. Е., Amelkina, G. A., Хаспеков, Л. Г., Skrebitsky, V. G., & Illarioshkin, S. N. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914050022 · Cited by 110
Ceruloplasmin-ferroportin system of iron traffic in vertebrates
Musci, G. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.204 · Cited by 111
Kono, S. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00007-7 · Cited by 107
Ceruloplasmin: Macromolecular Assemblies with Iron-Containing Acute Phase Proteins
Самыгина, В. Р., Av, S., Bourenkov, G. P., Petoukhov, M. V., Pulina, M. O., Zakharova, E. T., Vasilyev, V. B., Bartunik, H. D., & Svergun, D. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067145 · Cited by 101
Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma
Farkas, R. H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0872 · Cited by 101
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
Wang, B., & Wang, X. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180508113025 · Cited by 104
Hereditary Causes of Disturbed Iron Homeostasis in the Central Nervous System
Ponka, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.022 · Cited by 99
Song, D., Song, Y., Hadziahmetovic, M., Zhong, Y., & Dunaief, J. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.020 · Cited by 96
Age-dependent and gender-specific changes in mouse tissue iron by strain
Hahn, P., Song, Y., Ying, G.-S., He, X., Beard, J., & Dunaief, J. L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.06.006 · Cited by 98
“Total non-heme iron levels in liver, heart, and brain were quantified using a modified bathophenanthroline-based spectrophotometric protocol originally described by Torrance and Bothwell (Torrance and Bothwell, 1968; Patel et al., 2002).”
MethodNeurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms
Meyer, E., Kurian, M. A., & Hayflick, S. J. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-025011 · Cited by 97
Inherited Disorders of Iron Overload
Pantopoulos, K. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00103 · Cited by 101
Ceruloplasmin Protects Injured Spinal Cord from Iron-Mediated Oxidative Damage
Rathore, K. I., Kerr, B. J., Redensek, A., López‐Vales, R., Jeong, S. Y., Ponka, P., & David, S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3649-08.2008 · Cited by 98
Self-citationBurkhart, A., Skjørringe, T., Johnsen, K. B., Siupka, P., Thomsen, L. B., Nielsen, M. S., Thomsen, L. L., & Moos, T. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9582-7 · Cited by 98
Hinarejos, I., Machuca, C., Sancho, P., & Espinós, C. (2020) · Antioxidants · doi:10.3390/antiox9101020 · Cited by 94
Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke
Altamura, C., Squitti, R., Pasqualetti, P., Gaudino, C., Palazzo, P., Tibuzzi, F., Lupoi, D., Cortesi, M., Rossini, P. M., & Vernieri, F. (2009) · Stroke · doi:10.1161/strokeaha.108.536714 · Cited by 94
Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson’s disease
You, L., Li, F., Wang, L., Zhao, S., Wang, S.-M., Zhang, L.-L., Zhang, L.-H., Duan, X.-L., Yu, P., & Chang, Y. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.071 · Cited by 92
Serum iron and copper status and oxidative stress in severe and mild preeclampsia
Serdar, Z., Sürmen-Gür, E., & Develioğlu, O. H. (2005) · Cell Biochemistry and Function · doi:10.1002/cbf.1235 · Cited by 91
The neurotoxicity of iron, copper and cobalt in Parkinson’s disease through ROS-mediated mechanisms
Lan, A. P., Chen, J., Chai, Z., & Hu, Y. (2016) · BioMetals · doi:10.1007/s10534-016-9942-4 · Cited by 92
Genetic contributions to Parkinson's disease
Huang, Y. M., Cheung, L., Rowe, D. B., & Halliday, G. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.007 · Cited by 91
Levi, S., & Tiranti, V. (2019) · Pharmaceuticals · doi:10.3390/ph12010027 · Cited by 90
Iron Homeostasis and Metabolism: Two Sides of a Coin
Venkataramani, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62026-4_3 · Cited by 96
Brain Iron Metabolism, Redox Balance and Neurological Diseases
Gao, G., You, L., Zhang, J. J., Chang, Y., & Yu, P. (2023) · Antioxidants · doi:10.3390/antiox12061289 · Cited by 95
Kolusarı, A., Kurdoğlu, M., Yıldızhan, R., Adali, E., Edirne, T., Çebi, A., Demir, H., & Yoruk, I. H. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600622 · Cited by 88
Functional relevance of ceruloplasmin mutations in Parkinson's Disease
Hochstrasser, H., Tomiuk, J., Walter, U., Behnke, S., Spiegel, J., Krüger, R., Becker, G., Riess, O., & Berg, D. (2005) · The FASEB Journal · doi:10.1096/fj.04-3486fje · Cited by 87
Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin
Rhodes, S. L., Buchanan, D. D., Ahmed, I., Taylor, K. D., Loriot, M., Sinsheimer, J. S., Bronstein, J. M., Elbaz, A., Mellick, G. D., Rotter, J. I., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.019 · Cited by 87
Advances in multimodal neuroimaging: Hybrid MR–PET and MR–PET–EEG at 3T and 9.4T
Shah, N. J., Oros‐Peusquens, A., Arrubla, J., Zhang, K., Warbrick, T., Mauler, J., Vahedipour, K., Romanzetti, S., Felder, J., Celik, A., et al. (2012) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2012.11.027 · Cited by 86
Muenchhoff, J., Poljak, A., Song, F., Raftery, M. J., Brodaty, H., Duncan, M. W., McEvoy, M., Attia, J., Schofield, P. W., & Sachdev, P. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141266 · Cited by 83
Zarruk, J. G., Berard, J. L., dos Santos, R. P., Kroner, A., Lee, J., Arosio, P., & David, S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.001 · Cited by 79
Self-citationMetals in alzheimer's disease: a systemic perspective
Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 80
Metadata
- Authors
- Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S.
- Affiliations
- Montreal General Hospital (CA)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-08-01
- Volume
- 22
- Issue
- 15
- Pages
- 6578-6586
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6758125
- OpenAlex
- W1595395957
- Cited by
- 379
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 14 · 2020: 12 · 2019: 11 · 2018: 22 · 2017: 17 · 2016: 11 · 2015: 24 · 2014: 24 · 2013: 15 · 2012: 22
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Parkinson's Disease Foundation
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- ceruloplasmin, iron homeostasis, central nervous system, ferroxidase, oxidative damage, oxidative stress, lipid peroxidation, cerebellum, brainstem, dopaminergic neurons, motor coordination deficits, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, iron accumulation
- MeSH terms
- Animals, Astrocytes, Brain Stem, Cell Survival, Cells, Cultured, Central Nervous System, Ceruloplasmin, Disease Models, Animal, Free Radicals, Iron, Liver, Neurons, Transferrin, Lipid Peroxidation, Mice, Knockout, Oxidative Stress, Gene Targeting, Motor Skills Disorders, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review